| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/20/2001 | WO2001096525A2 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096524A2 A novel polypeptide, a human sigma receptor 10.67 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096400A2 52871, a novel human g protein coupled receptor and uses thereof |
| 12/20/2001 | WO2001096399A2 Novel interferon-induced tetraspan protein and nucleic acids encoding same |
| 12/20/2001 | WO2001096398A2 Uncoupling proteins as targets for the treatment of heart failure |
| 12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
| 12/20/2001 | WO2001096396A2 Heliothis glutamate receptor |
| 12/20/2001 | WO2001096395A2 Biosynthetic oncolytic molecules and uses therefor |
| 12/20/2001 | WO2001096394A2 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096391A2 55p4h4: gene expressed in various cancers |
| 12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096389A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096387A1 A novel polypeptide - estrogen receptor related protein 9.13 and a polynucleotide encoding the same |
| 12/20/2001 | WO2001096386A1 A novel polypeptide - human neuropeptide y protein 9 and a polynucleotide encoding the same |
| 12/20/2001 | WO2001096385A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | WO2001096384A1 A novel polypeptide, a human zinc-finger protein 15 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096381A2 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION |
| 12/20/2001 | WO2001096380A2 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 12/20/2001 | WO2001096379A2 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096375A2 33358, a novel human ankyrin family member and uses thereof |
| 12/20/2001 | WO2001096373A2 Fluorescent timer proteins and methods for their use |
| 12/20/2001 | WO2001096372A2 Zinc transporters proteins and their use in medicinal preparations |
| 12/20/2001 | WO2001096371A2 Adipose-related gene |
| 12/20/2001 | WO2001096370A2 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001096364A2 Peptides that stimulate cell survival and axon regeneration |
| 12/20/2001 | WO2001096361A1 Method of controlling the binding of calmyrin to presenilin |
| 12/20/2001 | WO2001096359A1 Compositions, methods, and kits relating to resistin-like molecules |
| 12/20/2001 | WO2001095934A2 The use of plant oil-bodies in vaccine delivery systems |
| 12/20/2001 | WO2001095933A2 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | WO2001095929A2 Interferon for treatment of multiple sclerosis |
| 12/20/2001 | WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 12/20/2001 | WO2001095927A1 P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain |
| 12/20/2001 | WO2001095926A1 Immunosuppressor agent derived from morbillivirus |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095860A2 Probes for chondrogenesis |
| 12/20/2001 | WO2001095855A2 Pregnancy-associated plasma protein-e (papp-e) |
| 12/20/2001 | WO2001095785A2 Modulation of immune response and methods based thereon |
| 12/20/2001 | WO2001095725A1 Biological control of pest animals |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001095709A1 Mouse showing neurofibril change due to senile dementia |
| 12/20/2001 | WO2001095708A1 Vitamin d receptor-deficient cell line |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001079259A8 Javelinization of protein antigens to heat shock proteins |
| 12/20/2001 | WO2001070764A3 Epitopes of mycobacterium tuberculosis secreted antigens and uses thereof |
| 12/20/2001 | WO2001066567A3 Design, synthesis and use of affinity ligands |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001057274A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 12/20/2001 | WO2001055725A3 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 12/20/2001 | WO2001055367A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055306A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055303A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055181A3 Recombinant multivalent malarial vaccines against plasmodium vivax |
| 12/20/2001 | WO2001054719A3 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 12/20/2001 | WO2001054474A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001053531A3 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
| 12/20/2001 | WO2001051521A3 Methods of identifying modulators of the fgf receptor |
| 12/20/2001 | WO2001051517A3 Candida hemolysin - like proteins and their uses |
| 12/20/2001 | WO2001051045A3 Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001049823A3 Assays for detection of bacillus anthracis |
| 12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
| 12/20/2001 | WO2001046390A3 Method of inactivating microorganisms |
| 12/20/2001 | WO2001044454A3 Root-specific promoter |
| 12/20/2001 | WO2001044295A3 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 12/20/2001 | WO2001044292A3 Wasp (wiskott-aldrich syndrome protein) family protein fragments, and use thereof |
| 12/20/2001 | WO2001040281A3 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 12/20/2001 | WO2001034770A3 Gene expression modulated by activation of microglia or macrophages |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001024822A3 Pharmaceutical composition comprising an antigen |
| 12/20/2001 | WO2001023592A3 Methods for making recombinant proteins using apoptosis inhibitors |
| 12/20/2001 | WO2001002552A3 Double transgenic animals as models for neurodegenerative disease |
| 12/20/2001 | WO2000071080A9 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 12/20/2001 | WO2000068387A3 Nucleic acids and proteins with interferon-beta activity |
| 12/20/2001 | WO2000067775A9 Fibroblast growth factor 15 |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000034309A9 Cloning and characterization of a cd2 binding protein (cd2bp2) |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000020593A9 Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | WO1999057137A9 Compositions and methods involving regulation of mammalian circadian rhythms |
| 12/20/2001 | WO1998020029A3 Hnf3-delta compositions |
| 12/20/2001 | US20010054185 Transgenic mouse embryo; for use as a model in the treatment of drug abuse |
| 12/20/2001 | US20010053848 Reaction product of protein g and receptor |
| 12/20/2001 | US20010053761 Method for administering aspb28-human insulin |
| 12/20/2001 | US20010053539 Polypeptide for use in the diagnosis and treatment of blood, kidney and live disoders |
| 12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 12/20/2001 | US20010053537 Electrophoresis separation and treatment of samples |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053533 Detecting infectious protein in solution; prepare solution composed from body fluid or fluidized organ expose to chromatographic column, detect infectious protein |
| 12/20/2001 | US20010053532 Detecting agonist or antagonist of binding protein; incubation of agonist/antagonist with binding protein, monitor response from binding protein |
| 12/20/2001 | US20010053367 Vaccines expressed in plants |
| 12/20/2001 | US20010053366 Method of removing endotoxin from vaccines |